Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Bigkahuna57on Sep 03, 2024 2:58pm
213 Views
Post# 36206679

RE:RE:RE:RE:RE:RE:RE:News Out !

RE:RE:RE:RE:RE:RE:RE:News Out !@enriquesuave, I agree. 

But to my point - that would depend on whether the licensee is negotiating for a piece of the pie to execute the license agreement. If you or I were negotiating I'd include it - why not.  I think Roger and Ms. K have had all types of preditory offers, many of which don't include "standard" or "traditional" agreement conditions. I'd be very surprised if TLT hasn't already had low-ball and "ugly-terms" offers with NDA's. Which is why we haven't heard of it and the FOMO hasn't already begun.

I think it will only take the first offer made public to start the FOMO. However, if I negotiate an agreement it would include an NDA and right-of-first refusal.  If I was Roger, I'd agree and add successive additional 10% performance and/or milestone payments after proof of concept (phase II patient trial(s)).  

IMO.

GLTA. Regards, BK.
<< Previous
Bullboard Posts
Next >>